Ideaya Biosciences Inc (IDYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2018 | 12-2017 | |
| Cash Flows From Operating Activities | ||
| Net Income | -12,732 | -11,862 |
| Depreciation Amortization | 109 | 364 |
| Accounts payable and accrued liabilities | 500 | N/A |
| Other Working Capital | 954 | 1,564 |
| Other Operating Activity | -283 | -2,290 |
| Operating Cash Flow | $-11,452 | $-12,224 |
| Cash Flows From Investing Activities | ||
| Change In Deposits | -74,617 | N/A |
| PPE Investments | -399 | -1,757 |
| Other Investing Activity | 0 | -7,170 |
| Investing Cash Flow | $-75,016 | $-8,927 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 56 | N/A |
| Other Financing Activity | 105,358 | 17,490 |
| Financing Cash Flow | $105,414 | $17,490 |
| Beginning Cash Position | 6,032 | 9,693 |
| End Cash Position | 24,978 | 6,032 |
| Net Cash Flow | $18,946 | $-3,661 |
| Free Cash Flow | ||
| Operating Cash Flow | -11,452 | -12,224 |
| Capital Expenditure | -399 | N/A |
| Free Cash Flow | -11,851 | -12,224 |